Riposte Capital LLC acquired a new position in shares of Bath & Body Works, Inc. (NYSE:BBWI – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 260,000 shares of the company’s stock, valued at approximately $10,080,000. Bath & Body Works accounts for approximately 1.9% of Riposte Capital LLC’s holdings, making the stock its 16th biggest holding.
A number of other hedge funds have also bought and sold shares of BBWI. Golden State Wealth Management LLC bought a new stake in shares of Bath & Body Works during the fourth quarter valued at approximately $26,000. SRS Capital Advisors Inc. raised its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock worth $26,000 after buying an additional 329 shares during the last quarter. True Wealth Design LLC lifted its stake in shares of Bath & Body Works by 5,270.0% in the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after buying an additional 1,054 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after buying an additional 335 shares during the last quarter. Finally, Lindbrook Capital LLC grew its holdings in shares of Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock valued at $37,000 after buying an additional 431 shares during the last quarter. Institutional investors own 95.14% of the company’s stock.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the stock. Piper Sandler raised their price target on shares of Bath & Body Works from $36.00 to $39.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Robert W. Baird raised their target price on Bath & Body Works from $45.00 to $47.00 and gave the company an “outperform” rating in a report on Friday, February 28th. Deutsche Bank Aktiengesellschaft upped their price target on Bath & Body Works from $51.00 to $52.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Argus restated a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Citigroup raised shares of Bath & Body Works from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $40.00 to $48.00 in a report on Friday, February 28th. Five research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $45.06.
Bath & Body Works Stock Performance
Shares of NYSE:BBWI opened at $30.24 on Monday. The firm has a market capitalization of $6.48 billion, a PE ratio of 7.38, a price-to-earnings-growth ratio of 0.92 and a beta of 1.89. The firm has a fifty day moving average of $35.70 and a 200 day moving average of $33.99. Bath & Body Works, Inc. has a 52-week low of $26.21 and a 52-week high of $52.99.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.04 by $0.05. The firm had revenue of $2.79 billion for the quarter, compared to analysts’ expectations of $2.78 billion. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were given a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.65%. Bath & Body Works’s dividend payout ratio is currently 21.98%.
Bath & Body Works announced that its Board of Directors has approved a share repurchase program on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to buy up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s leadership believes its stock is undervalued.
Bath & Body Works Profile
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
Read More
- Five stocks we like better than Bath & Body Works
- What is Forex and How Does it Work?
- Rising E-Commerce Sales May Spark a Stock Breakout—What to Buy
- How to Choose Top Rated Stocks
- Chinese Fintech FinVolution: Buy, Sell, or Hold?
- How to Start Investing in Real Estate
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.